These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15742660)

  • 1. The macro-economic impact of a foot-and-mouth disease incursion in New Zealand.
    Belton DJ
    Dev Biol (Basel); 2004; 119():457-61. PubMed ID: 15742660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foot-and-Mouth disease control using vaccination: the Dutch experience in 2001.
    Pluimers FH
    Dev Biol (Basel); 2004; 119():41-9. PubMed ID: 15742617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [FMD and international trade relations--conditions and consequences].
    Zwingmann W; Fiedler J
    Dtsch Tierarztl Wochenschr; 2001 Dec; 108(12):518-21. PubMed ID: 11822167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for the control of foot-and-mouth disease in Uruguay.
    Ugarte R
    Dev Biol (Basel); 2004; 119():415-21. PubMed ID: 15742654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The control of foot-and-mouth disease in Botswana: special reference to vaccination.
    Letshwenyo M; Fanikiso M; Chimbombi M
    Dev Biol (Basel); 2004; 119():403-13. PubMed ID: 15742653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the benefits of vaccination when used in combination with stamping-out measures against hypothetical introductions of foot-and-mouth disease into New Zealand: a simulation study.
    Sanson RL; Rawdon T; Owen K; Hickey K; van Andel M; Yu ZD
    N Z Vet J; 2017 May; 65(3):124-133. PubMed ID: 27870922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination as a control measure during the outbreak of foot-and-mouth disease in 2000 in Korea.
    Park JH; Park JY; Kim YJ; Oem JK; Lee KN; Kye SJ; Joo YS
    Dev Biol (Basel); 2004; 119():63-70. PubMed ID: 15742619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for the control of foot-and-mouth disease in Southeast Asia (SEAFMD).
    Edwards JR
    Dev Biol (Basel); 2004; 119():423-31. PubMed ID: 15742655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies II: Waiting Periods After Emergency Vaccination in FMD Free Countries.
    Geale DW; Barnett PV; Clarke GW; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):388-406. PubMed ID: 24131661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.
    Roth JA
    Dev Biol (Basel); 2004; 119():267-72. PubMed ID: 15742638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of vaccines in South American foot-and-mouth disease eradication programmes.
    Saraiva V; Darsie G
    Dev Biol (Basel); 2004; 119():33-40. PubMed ID: 15742616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroeconomic impact of foot-and-mouth disease vaccination strategies for an outbreak in the Midwestern United States: A computable general equilibrium.
    Miller M; Liu L; Shwiff S; Shwiff S
    Transbound Emerg Dis; 2019 Jan; 66(1):156-165. PubMed ID: 30113131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foot and mouth disease: lessons to be learned from the experience of France.
    Chmitelin I; Moutou F
    Rev Sci Tech; 2002 Dec; 21(3):731-7, 723-30. PubMed ID: 12523710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatio-temporal patterns of foot-and-mouth disease transmission in cattle between 2007 and 2015 and quantitative assessment of the economic impact of the disease in Niger.
    Souley Kouato B; Thys E; Renault V; Abatih E; Marichatou H; Issa S; Saegerman C
    Transbound Emerg Dis; 2018 Aug; 65(4):1049-1066. PubMed ID: 29508559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foot-and-mouth disease control using vaccination: South African experience.
    Brückner GK; Vosloo W; Cloete M; Dungu B; Du Plessis BJ
    Dev Biol (Basel); 2004; 119():51-62. PubMed ID: 15742618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management strategies for vaccinated animals after an outbreak of foot-and-mouth disease and the impact on return to trade.
    Bradhurst R; Garner G; East I; Death C; Dodd A; Kompas T
    PLoS One; 2019; 14(10):e0223518. PubMed ID: 31603929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do resources influence control measures during a simulated outbreak of foot and mouth disease in Australia?
    Roche SE; Garner MG; Wicks RM; East IJ; de Witte K
    Prev Vet Med; 2014 Mar; 113(4):436-46. PubMed ID: 24412502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating vaccination strategies to control foot-and-mouth disease: a country comparison study.
    Rawdon TG; Garner MG; Sanson RL; Stevenson MA; Cook C; Birch C; Roche SE; Patyk KA; Forde-Folle KN; Dubé C; Smylie T; Yu ZD
    Epidemiol Infect; 2018 Jul; 146(9):1138-1150. PubMed ID: 29785893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the foot and mouth disease outbreak in The Netherlands in 2001.
    Pluimers FH; Akkerman AM; van der Wal P; Dekker A; Bianchi A
    Rev Sci Tech; 2002 Dec; 21(3):711-21. PubMed ID: 12523709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An economic assessment of foot and mouth disease in Japan.
    Hayama Y; Osada Y; Oushiki D; Tsutsui T
    Rev Sci Tech; 2017 Apr; 36(1):207-215. PubMed ID: 28926015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.